Alternatively, a CNS action of LGI1 antibodies may mediate pain consistent with observations including the frequent concurrent encephalopathy, striking binding to CNS tissue, and the truncal distribution reminiscent of central cord syndromes. This evidence concerns the gene LGI1 and Central Cord Syndrome.